Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Previously Marketed

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2003

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Protein

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

DRUG BANK

2

EU-Orphan Drug

2

EVMPD

2

FDA ORPHAN DRUG

2

All Match

Any Match

Exclude Selected

Exclude Selected

Protein Type

MONOCLONAL ANTIBODY

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

VARIOUS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

THERAPEUTIC RADIOPHARMACEUTICALS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER THERAPEUTIC RADIOPHARMACEUTICALS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Iodine (<sup>131</sup>I) compounds

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "EU ORPHAN DRUG|Withdrawn|Treatment of follicular lymphoma" in comments (approximate match)

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

TOSITUMOMAB I-131

K1KT5M40JC

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Export Data
Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

US Previously Marketed

First approved in 2003

Class:

PROTEIN

TOSITUMOMAB

0343IGH41U

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Export Data
Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

US Previously Marketed

First approved in 2003

Class:

PROTEIN

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1